If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Atsushi Osoegawa is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 19 Similar Profiles
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Lung Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
CD274 Antigen Medicine & Life Sciences
Indoleamine-Pyrrole 2,3,-Dioxygenase Medicine & Life Sciences
Squamous Cell Carcinoma Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Lung Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2002 2019

  • 551 Citations
  • 13 h-Index
  • 52 Article
  • 2 Review article

18F-FDG uptake in PET/CT is a potential predictive biomarker of response to anti-PD-1 antibody therapy in non-small cell lung cancer

Takada, K., Toyokawa, G., Yoneshima, Y., Tanaka, K., Okamoto, I., Shimokawa, M., Wakasu, S., Haro, A., Osoegawa, A., Tagawa, T., Oda, Y., Nakanishi, Y. & Mori, M., Dec 1 2019, In : Scientific reports. 9, 1, 13362.

Research output: Contribution to journalArticle

Open Access
Fluorodeoxyglucose F18
Non-Small Cell Lung Carcinoma
Cell Death
Biomarkers
Antibodies
4 Citations (Scopus)

A Clinicopathological and Prognostic Analysis of PD-L2 Expression in Surgically Resected Primary Lung Squamous Cell Carcinoma

Matsubara, T., Takada, K., Azuma, K., Takamori, S., Toyokawa, G., Haro, A., Osoegawa, A., Tagawa, T., Kawahara, A., Akiba, J., Okamoto, I., Nakanishi, Y., Oda, Y., Hoshino, T. & Maehara, Y., Jun 15 2019, In : Annals of Surgical Oncology. 26, 6, p. 1925-1933 9 p.

Research output: Contribution to journalArticle

Squamous Cell Carcinoma
Ligands
Lung
CD274 Antigen
Immunotherapy

Association between peripheral blood markers and immune-related factors on tumor cells in patients with resected primary lung adenocarcinoma

Takada, K., Shimokawa, M., Tanaka, K., Kouhashi, K., Haro, A., Osoegawa, A., Tagawa, T., Azuma, K., Okamoto, I., Oda, Y. & Mori, M., Jun 1 2019, In : PloS one. 14, 6, e0217991.

Research output: Contribution to journalArticle

Open Access
Indoleamine-Pyrrole 2,3,-Dioxygenase
Immunologic Factors
adenocarcinoma
Cell death
Tumors
1 Citation (Scopus)

Association of Low Body Mass Index with Poor Clinical Outcomes after Resection of Non-small Cell Lung Cancer

Takada, K., Shimokawa, M., Akamine, T., Ono, Y., Haro, A., Osoegawa, A., Tagawa, T. & Mori, M., Apr 1 2019, In : Anticancer research. 39, 4, p. 1987-1996 10 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Body Mass Index
Disease-Free Survival
Survival
CD274 Antigen

Clinical and Prognostic Significance of the Epithelial–Mesenchymal Transition in Stage IA Lung Adenocarcinoma: A Propensity Score–Matched Analysis

Matsubara, T., Tagawa, T., Takada, K., Toyokawa, G., Shimokawa, M., Kozuma, Y., Akamine, T., Haro, A., Osoegawa, A. & Mori, M., Jul 1 2019, In : Clinical Lung Cancer. 20, 4, p. e504-e513

Research output: Contribution to journalArticle

Propensity Score
Vimentin
Cadherins
Neoplasms
Disease-Free Survival